Division of Trauma & Acute Care Surgery, 1867Tufts University School of Medicine, Tufts Medical Center, Boston, MA, USA.
1867Tufts Clinical and Translational Science Institute, Tufts University, and Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.
Am Surg. 2020 Dec;86(12):1629-1635. doi: 10.1177/0003134820972084. Epub 2020 Nov 24.
The role of an acute care surgery (ACS) service during the COVID-19 pandemic is not well established.
A retrospective review of the ACS service performance in an urban tertiary academic medical center. The study was performed between January and May 2020. The demographics, clinical characteristics, and outcomes of patients treated by the ACS service 2 months prior to the COVID surge (pre-COVID group) and during the first 2 months of the COVID-19 pandemic (surge group) were compared.
Trauma and emergency general surgery volumes decreased during the surge by 38% and 57%, respectively; but there was a 64% increase in critically ill patients. The proportion of patients in the Department of Surgery treated by the ACS service increased from 40% pre-COVID to 67% during the surge. The ACS service performed 32% and 57% of all surgical cases in the Department of Surgery during the pre-COVID and surge periods, respectively. The ACS service managed 23% of all critically ill patients in the institution during the surge. Critically ill patients with and without confirmed COVID-19 infection treated by ACS and non-ACS intensive care units during the surge did not differ in demographics, indicators of clinical severity, or hospital mortality:13.4% vs. 13.5% ( = .99) for all critically ill patients; and 13.9% vs. 27.4% ( = .12) for COVID-19 critically ill patients.
Acute care surgery is an "essential" service during the COVID-19 pandemic, capable of managing critically ill nonsurgical patients while maintaining the provision of trauma and emergent surgical services.
III.
Therapeutic.
急性护理外科(ACS)服务在 COVID-19 大流行期间的作用尚未得到充分确立。
对城市三级学术医疗中心 ACS 服务绩效进行回顾性研究。该研究于 2020 年 1 月至 5 月进行。比较 ACS 服务在 COVID 激增前 2 个月(COVID 前组)和 COVID-19 大流行的头 2 个月(激增组)治疗的患者的人口统计学、临床特征和结局。
创伤和急诊普通外科手术量在激增期间分别下降了 38%和 57%;但危重症患者增加了 64%。外科部门由 ACS 服务治疗的患者比例从 COVID 前的 40%增加到激增期间的 67%。ACS 服务在 COVID 前和激增期间分别完成了外科部门所有手术病例的 32%和 57%。ACS 服务在激增期间管理了机构中所有危重症患者的 23%。ACS 和非 ACS 重症监护病房治疗的有和没有确诊 COVID-19 感染的危重症患者在人口统计学、临床严重程度指标或住院死亡率方面没有差异:所有危重症患者为 13.4%与 13.5%(=.99);COVID-19 危重症患者为 13.9%与 27.4%(=.12)。
急性护理外科是 COVID-19 大流行期间的“必要”服务,能够在维持创伤和紧急外科服务的同时管理非外科危重症患者。
III。
治疗性。